Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

NRx Pharmaceuticals, Inc. (NRXP) vs Tiziana Life Sciences Ltd (TLSA)

NRx Pharmaceuticals, Inc. and Tiziana Life Sciences Ltd are both Biotechnology companies. NRx Pharmaceuticals, Inc. and Tiziana Life Sciences Ltd are of similar size ($131.2M and $131.1M). Tiziana Life Sciences Ltd has the higher net margin (0.00% vs −691.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, NRx Pharmaceuticals, Inc. leads on 6 and Tiziana Life Sciences Ltd on 5.

Valuation

Metric NRXP TLSA Biotechnology median
P/E n/m n/m 7.88
P/S 33.28 n/m 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.04 0.74
EV/Sales 27.01 n/m 10.73
Earnings yield (18.33%) (51.86%) (28.84%)
Free cash flow yield (18.30%) 0.00% (23.03%)

Profitability

Metric NRXP TLSA Biotechnology median
Gross margin 46.64% 0.00% 65.16%
Operating margin (586.15%) — 0.00%
Net margin (691.78%) 0.00% 0.00%
Free cash flow margin (609.02%) 0.00% 0.00%
Return on equity 131.22% 0.00% (57.72%)
Return on assets (120.41%) 0.00% (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NRXP TLSA Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 43.22% (45.45%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NRXP TLSA Biotechnology median
Debt to equity (2.42) 0.00 0.00
Current ratio 0.86 0.76 4.73
Net debt to EBITDA 0.48 0.19 0.96

Dividend

Metric NRXP TLSA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric NRXP TLSA Biotechnology median
Market cap 131.19m 131.11m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack